Company: APM
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001213900-25-037669
Chunk: 222

Company: Aptorum Group Ltd
Filing Date: 2025-04-30
Form: 20-F
Item: Item 19
Chunk 222
---
,528                        ( 68,161,722  
  Total equity attributable to the shareholders of Aptorum Group Limited                                                                                                                                                        21,134,514                          24,846,236  
  Non-controlling interests                                                                                                                                                                                                    ( 9,357,453                         ( 9,462,883  
  Total equity                                                                                                                                                                                                                  11,777,061                          15,383,353  
  Total Liabilities and Equity                                                                                                                                                                              $                   16,130,223      $                   20,640,091  

See accompanying notes to the consolidated financial
statements.

F-3

APTORUM GROUP LIMITED

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE
LOSS

For Years Ended December 31, 2024, 2023 and
2022

(Stated in U. S. Dollars, except for number of
shares)

                                                                                    Year Ended                         Year Ended                          Year Ended                      
                                                                                    December 31,                       December 31,                        December 31,                    
                                                                                    2024                               2023                                2022                            
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Revenue                                                                                                                                                                                  
  Healthcare services income                                                        $                           -      $                      431,378      $                    1,295,889  
  Operating expenses                                                                                                                                                                       
  Cost of healthcare services                                                                                   -                           ( 420,812                         ( 1,215,824  
  Research and development expenses                                                                   ( 2,195,161                         ( 5,198,329                         ( 9,219,595  
  General and administrative fees                                                                       ( 669,486                         ( 1,930,637                         ( 5,220,405  
  Legal and professional fees                                                                           ( 803,285                         ( 2,538,161                         ( 2,888,140  
  Other operating expenses                                                                              ( 272,609                         ( 1,067,690                           ( 261,038  
  Total operating expenses                                                                            ( 3,940,541                        ( 11,155,629                        ( 18,805,002  
  Other (expense) income, net                                                                                                                                                              
  Loss on investments in marketable securities, net                                                             -                             ( 9,266                           ( 134,134  
  Unrealized gain from fair value change of the long-term investments, net                                      -                           6,431,088                           6,108,872